During a search for targets that could be used to increase the response to ovarian cancer drugs, scientists have made new discoveries about the cell cycle, as well as the connections between that cycle and cellular metabolism.
"By searching for ways to enhance taxane sensitivity, we discovered a more general target that is important for cell division," noted Robert Bast, vice president for translational research at Houston's M.D. Anderson Cancer Center and the senior author of the paper, which appeared in the August 2010 issue of Cancer Cell.
Though it can stem from some of the same mutations as breast cancer, ovarian cancer remains a more serious diagnosis--mostly …
No comments:
Post a Comment